help button home button Am J Pathol The FASEB Journal
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hruban, R. H.
Right arrow Articles by Kern, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hruban, R. H.
Right arrow Articles by Kern, S. E.
(American Journal of Pathology. 2000;156:1821-1825.)
© 2000 American Society for Investigative Pathology

Commentary

Genetic Progression in the Pancreatic Ducts

Ralph H. Hruban*{dagger}, Robb E. Wilentz* and Scott E. Kern*{dagger}

From the Departments of Pathology*
and Oncology,{dagger}
The Johns Hopkins Medical Institutions, Baltimore, Maryland

Abstract




This article has been cited by other articles:


Home page
 FASEB J.Home page
A. Vincent, M.-P. Ducourouble, and I. Van Seuningen
Epigenetic regulation of the human mucin gene MUC4 in epithelial cancer cell lines involves both DNA methylation and histone modifications mediated by DNA methyltransferases and histone deacetylases
FASEB J, August 1, 2008; 22(8): 3035 - 3045.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
G. Feldmann and A. Maitra
Molecular Genetics of Pancreatic Ductal Adenocarcinomas and Recent Implications for Translational Efforts
J. Mol. Diagn., March 1, 2008; 10(2): 111 - 122.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. M. Winter, A. H. Ting, F. Vilardell, E. Gallmeier, S. B. Baylin, R. H. Hruban, S. E. Kern, and C. A. Iacobuzio-Donahue
Absence of E-Cadherin Expression Distinguishes Noncohesive from Cohesive Pancreatic Cancer
Clin. Cancer Res., January 15, 2008; 14(2): 412 - 418.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. V. Gold, Z. Karanjawala, D. E. Modrak, D. M. Goldenberg, and R. H. Hruban
PAM4-Reactive MUC1 Is a Biomarker for Early Pancreatic Adenocarcinoma
Clin. Cancer Res., December 15, 2007; 13(24): 7380 - 7387.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
R. E Brand, M. M Lerch, W. S Rubinstein, J. P Neoptolemos, D. C Whitcomb, R. H Hruban, T. A Brentnall, H. T Lynch, M. I Canto, and Participants of the Fourth International Symposium
Advances in counselling and surveillance of patients at risk for pancreatic cancer
Gut, October 1, 2007; 56(10): 1460 - 1469.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Kojima, S. M. Vickers, N. V. Adsay, N. C. Jhala, H.-G. Kim, T. R. Schoeb, W. E. Grizzle, and C. A. Klug
Inactivation of Smad4 Accelerates KrasG12D-Mediated Pancreatic Neoplasia
Cancer Res., September 1, 2007; 67(17): 8121 - 8130.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
M. A Khalifa
Intraoperative assessment of the Whipple resection specimen
J. Clin. Pathol., September 1, 2007; 60(9): 975 - 980.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
D. Mahadevan and D. D. Von Hoff
Tumor-stroma interactions in pancreatic ductal adenocarcinoma
Mol. Cancer Ther., April 1, 2007; 6(4): 1186 - 1197.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Ueda, K. Fukamachi, Y. Matsuoka, N. Takasuka, F. Takeshita, A. Naito, M. Iigo, D. B. Alexander, M. A. Moore, I. Saito, et al.
Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas
Carcinogenesis, December 1, 2006; 27(12): 2497 - 2510.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
A. K. Rustgi
The molecular pathogenesis of pancreatic cancer: clarifying a complex circuitry.
Genes & Dev., November 15, 2006; 20(22): 3049 - 3053.
[Full Text] [PDF]

Home page
 GutHome page
J Kim, H A Reber, S M Dry, D Elashoff, S L Chen, N Umetani, M Kitago, O J Hines, K K Kazanjian, S Hiramatsu, et al.
Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins
Gut, November 1, 2006; 55(11): 1598 - 1605.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. M. Wiktor-Brown, C. A. Hendricks, W. Olipitz, and B. P. Engelward
Age-dependent accumulation of recombinant cells in the mouse pancreas revealed by in situ fluorescence imaging
PNAS, August 8, 2006; 103(32): 11862 - 11867.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
T. B. Deramaudt, M. Takaoka, R. Upadhyay, M. J. Bowser, J. Porter, A. Lee, B. Rhoades, C. N. Johnstone, R. Weissleder, S. R. Hingorani, et al.
N-Cadherin and Keratinocyte Growth Factor Receptor Mediate the Functional Interplay between Ki-RASG12V and p53V143A in Promoting Pancreatic Cell Migration, Invasion, and Tissue Architecture Disruption.
Mol. Cell. Biol., June 1, 2006; 26(11): 4185 - 4200.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
E. Giovannetti, V. Mey, S. Nannizzi, G. Pasqualetti, M. Del Tacca, and R. Danesi
Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer.
Mol. Cancer Ther., June 1, 2006; 5(6): 1387 - 1395.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
F Bergmann, S Aulmann, M N Wente, R Penzel, I Esposito, J Kleeff, H Friess, and P Schirmacher
Molecular characterisation of pancreatic ductal adenocarcinoma in patients under 40
J. Clin. Pathol., June 1, 2006; 59(6): 580 - 584.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
A. F. Hezel, A. C. Kimmelman, B. Z. Stanger, N. Bardeesy, and R. A. DePinho
Genetics and biology of pancreatic ductal adenocarcinoma.
Genes & Dev., May 15, 2006; 20(10): 1218 - 1249.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
N. Bardeesy, A. J. Aguirre, G. C. Chu, K.-h. Cheng, L. V. Lopez, A. F. Hezel, B. Feng, C. Brennan, R. Weissleder, U. Mahmood, et al.
From the Cover: Both p16Ink4a and the p19Arf-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse
PNAS, April 11, 2006; 103(15): 5947 - 5952.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. H. Hruban, N. V. Adsay, J. Albores-Saavedra, M. R. Anver, A. V. Biankin, G. P. Boivin, E. E. Furth, T. Furukawa, A. Klein, D. S. Klimstra, et al.
Pathology of Genetically Engineered Mouse Models of Pancreatic Exocrine Cancer: Consensus Report and Recommendations
Cancer Res., January 1, 2006; 66(1): 95 - 106.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Qian, J. Niu, M. Li, P. J. Chiao, and M.-S. Tsao
In vitro Modeling of Human Pancreatic Duct Epithelial Cell Transformation Defines Gene Expression Changes Induced by K-ras Oncogenic Activation in Pancreatic Carcinogenesis
Cancer Res., June 15, 2005; 65(12): 5045 - 5053.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. E. Dowen, T. Crnogorac-Jurcevic, R. Gangeswaran, M. Hansen, J. J. Eloranta, V. Bhakta, T. A. Brentnall, J. Luttges, G. Kloppel, and N. R. Lemoine
Expression of S100P and Its Novel Binding Partner S100PBPR in Early Pancreatic Cancer
Am. J. Pathol., January 1, 2005; 166(1): 81 - 92.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. Aguilar, J. M. Corominas, N. Malats, J. A. Pereira, M. Dufresne, F. X. Real, and P. Navarro
Tissue Plasminogen Activator in Murine Exocrine Pancreas Cancer: Selective Expression in Ductal Tumors and Contribution to Cancer Progression
Am. J. Pathol., October 1, 2004; 165(4): 1129 - 1139.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. T. Henke, B. R. Haddad, S. E. Kim, J. D. Rone, A. Mani, J. M. Jessup, A. Wellstein, A. Maitra, and A. T. Riegel
Overexpression of the Nuclear Receptor Coactivator AIB1 (SRC-3) during Progression of Pancreatic Adenocarcinoma
Clin. Cancer Res., September 15, 2004; 10(18): 6134 - 6142.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Takahashi, T. Oda, T. Hasebe, Y. Aoyagi, T. Kinoshita, M. Konishi, T. Nakagohri, K. Inoue, S. Takahashi, H. Kawahira, et al.
Biologically Different Subgroups of Invasive Ductal Carcinoma of the Pancreas: Dpc4 Status According to the Ratio of Intraductal Carcinoma Components
Clin. Cancer Res., June 1, 2004; 10(11): 3772 - 3779.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. E. Jones, M. J. Humphreys, F. Campbell, J. P. Neoptolemos, and M. T. Boyd
Comprehensive Analysis of Matrix Metalloproteinase and Tissue Inhibitor Expression in Pancreatic Cancer: Increased Expression of Matrix Metalloproteinase-7 Predicts Poor Survival
Clin. Cancer Res., April 15, 2004; 10(8): 2832 - 2845.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
J.-K. Lin, S.-C. Chang, Y.-C. Yang, and A. F.-Y. Li
Loss of Heterozygosity and DNA Aneuploidy in Colorectal Adenocarcinoma
Ann. Surg. Oncol., November 1, 2003; 10(9): 1086 - 1094.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. J. Grippo, P. S. Nowlin, M. J. Demeure, D. S. Longnecker, and E. P. Sandgren
Preinvasive Pancreatic Neoplasia of Ductal Phenotype Induced by Acinar Cell Targeting of Mutant Kras in Transgenic Mice
Cancer Res., May 1, 2003; 63(9): 2016 - 2019.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Matsubayashi, N. Sato, N. Fukushima, C. J. Yeo, K. M. Walter, K. Brune, F. Sahin, R. H. Hruban, and M. Goggins
Methylation of Cyclin D2 Is Observed Frequently in Pancreatic Cancer but Is Also an Age-related Phenomenon in Gastrointestinal Tissues
Clin. Cancer Res., April 1, 2003; 9(4): 1446 - 1452.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. A. French, E. K. Alexander, E. S. Cibas, V. Nose, J. Laguette, W. Faquin, J. Garber, F. Moore Jr, J. A. Fletcher, P. R. Larsen, et al.
Genetic and Biological Subgroups of Low-Stage Follicular Thyroid Cancer
Am. J. Pathol., April 1, 2003; 162(4): 1053 - 1060.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
N Howes and J P Neoptolemos
Risk of pancreatic ductal adenocarcinoma in chronic pancreatitis
Gut, December 1, 2002; 51(6): 765 - 766.
[Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
N. T. van Heek, A. K. Meeker, S. E. Kern, C. J. Yeo, K. D. Lillemoe, J. L. Cameron, G. J. A. Offerhaus, J. L. Hicks, R. E. Wilentz, M. G. Goggins, et al.
Telomere Shortening Is Nearly Universal in Pancreatic Intraepithelial Neoplasia
Am. J. Pathol., November 1, 2002; 161(5): 1541 - 1547.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. Hennig, X.-Z. Ding, W.-G. Tong, M. B. Schneider, J. Standop, H. Friess, M. W. Buchler, P. M. Pour, and T. E. Adrian
5-Lipoxygenase and Leukotriene B4 Receptor Are Expressed in Human Pancreatic Cancers But Not in Pancreatic Ducts in Normal Tissue
Am. J. Pathol., August 1, 2002; 161(2): 421 - 428.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
A V Biankin, S A Biankin, J G Kench, A L Morey, C-S Lee, D R Head, R P Eckstein, T B Hugh, S M Henshall, and R L Sutherland
Aberrant p16INK4A and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma
Gut, June 1, 2002; 50(6): 861 - 868.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
N. Fukushima, N. Sato, T. Ueki, C. Rosty, K. M. Walter, R. E. Wilentz, C. J. Yeo, R. H. Hruban, and M. Goggins
Aberrant Methylation of Preproenkephalin and p16 Genes in Pancreatic Intraepithelial Neoplasia and Pancreatic Ductal Adenocarcinoma
Am. J. Pathol., May 1, 2002; 160(5): 1573 - 1581.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. Ryu, J. Jones, N. J. Blades, G. Parmigiani, M. A. Hollingsworth, R. H. Hruban, and S. E. Kern
Relationships and Differentially Expressed Genes among Pancreatic Cancers Examined by Large-scale Serial Analysis of Gene Expression
Cancer Res., February 1, 2002; 62(3): 819 - 826.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. V. Biankin, J. G. Kench, A. L. Morey, C.-S. Lee, S. A. Biankin, D. R. Head, T. B. Hugh, S. M. Henshall, and R. L. Sutherland
Overexpression of p21WAF1/CIP1 is an Early Event in the Development of Pancreatic Intraepithelial Neoplasia
Cancer Res., December 1, 2001; 61(24): 8830 - 8837.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. Luttges, H. Galehdari, V. Brocker, I. Schwarte-Waldhoff, D. Henne-Bruns, G. Kloppel, W. Schmiegel, and S. A. Hahn
Allelic Loss Is Often the First Hit in the Biallelic Inactivation of the p53 and DPC4 Genes During Pancreatic Carcinogenesis
Am. J. Pathol., May 1, 2001; 158(5): 1677 - 1683.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. M. Henshall, D. I. Quinn, C. S. Lee, D. R. Head, D. Golovsky, P. C. Brenner, W. Delprado, P. D. Stricker, J. J. Grygiel, and R. L. Sutherland
Overexpression of the Cell Cycle Inhibitor p16INK4A in High-grade Prostatic Intraepithelial Neoplasia Predicts Early Relapse in Prostate Cancer Patients
Clin. Cancer Res., March 1, 2001; 7(3): 544 - 550.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
R. H. Hruban, M. Goggins, J. Parsons, and S. E. Kern
Progression Model for Pancreatic Cancer
Clin. Cancer Res., August 1, 2000; 6(8): 2969 - 2972.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society for Investigative Pathology.